Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02380274 · ClinicalTrials.gov registry record
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
A clinical trial, sponsored by Astellas Pharma Global Development.
- Completed
- Registry status
- 1,030
- Enrollment target
NCT02380274 is a clinical trial that has completed, run by Astellas Pharma Global Development. The registered enrollment target is 1,030 participants.
The verdict
NCT02380274 has completed, sponsored by Astellas Pharma Global Development.
- COMPLETED
- Registry status
- 1,030 participants
- Enrollment target
Study Summary
The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management. This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and triggers for treatment changes for CRPC as well as describe clinical outcomes based on patient characteristics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,030 participants |
| Start Date | 2015-03-27 |
| Est. Completion | 2021-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02380274
The ClinicalTrials.gov registry entry for NCT02380274 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,030 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma Global Development, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02380274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02380274 about?
NCT02380274 is a clinical study titled "Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)". The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management. This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and trigger...
What is the current status of trial NCT02380274?
This trial is currently completed. The enrollment target is 1,030 participants. The study started on 2015-03-27. Estimated completion is 2021-01-14.
Who is sponsoring clinical trial NCT02380274?
This trial is sponsored by Astellas Pharma Global Development, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.